Related Experiment Video

Updated: Aug 15, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

[Kinase inhibitors for the therapy of malignant melanoma]

Jürgen C Becker1, David Schrama, Eva-B Bröcker

  • 1Klinik für Dermatologie, Allergologie und Venerologie, Universitätsklinik Würzburg, Wüzburg. becker_jc@klinik.uni-wuerzburg.de

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|October 1, 2005
PubMed

Insights

Targeted therapy offers new melanoma treatment options by focusing on specific molecular pathways. Understanding melanoma genesis and progression guides the development of these advanced therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma genesis and progression are complex processes driven by molecular alterations.
  • Understanding these molecular mechanisms is crucial for developing effective treatments.
  • Signal transduction pathways play a key role in melanoma development.

Purpose of the Study:

  • To review therapeutic options for melanoma targeting specific signal transduction pathways.
  • To highlight the impact of basic and translational research on melanoma treatment.
  • To focus on the Ras/MAPK and PI3K/AKT pathways in melanoma therapy.

Main Methods:

  • Review of recent basic and translational research findings.
  • Analysis of molecular pathology and signal transduction pathways in melanoma.
  • Identification of targeted therapy strategies.

Main Results:

  • Increased understanding of melanoma molecular pathology.
  • Detailed analysis of key signal transduction pathways (Ras/MAPK, PI3K/AKT).
  • Identification of specific molecular targets for intervention.

Conclusions:

  • Targeted therapies offer promising new approaches for melanoma treatment.
  • Modulation of Ras/MAPK and PI3K/AKT pathways is a key strategy.
  • Continued research into molecular mechanisms will drive future therapeutic advancements.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...